Handelsbanken Fonder
CORT icon

Handelsbanken Fonder’s Corcept Therapeutics CORT Stock Holding History

Handelsbanken Fonder’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.21M Buy
36,881
+8,100
+28% +$489K 0.01% 639
2026
Q1 		$1.16M Hold
28,781
– – ﹤0.01% 976
2025
Q4 		$1M Buy
28,781
+3,500
+14% +$275K ﹤0.01% 1025
2025
Q3 		$2.1M Hold
25,281
– – 0.01% 709
2025
Q2 		$1.86M Sell
25,281
-2,700
-10% -$196K 0.01% 688
2025
Q1 		$3.2M Hold
27,981
– – 0.01% 516
2024
Q4 		$1.41M Sell
27,981
-3,000
-10% -$157K 0.01% 813
2024
Q3 		$1.43M Buy
30,981
+11,700
+61% +$416K 0.01% 789
2024
Q2 		$626K Sell
19,281
-600
-3% -$16.4K ﹤0.01% 1059
2024
Q1 		$501K Hold
19,881
– – ﹤0.01% 1159
2023
Q4 		$646K Hold
19,881
– – ﹤0.01% 1005
2023
Q3 		$542K Buy
19,881
+2,000
+11% +$57.9K ﹤0.01% 1016
2023
Q2 		$398K Hold
17,881
– – ﹤0.01% 1186
2023
Q1 		$387K Hold
17,881
– – ﹤0.01% 1136
2022
Q4 		$363K Sell
17,881
-5,079
-22% -$127K ﹤0.01% 1142
2022
Q3 		$589K Hold
22,960
– – ﹤0.01% 873
2022
Q2 		$546K Sell
22,960
-400
-2% -$8.71K ﹤0.01% 969
2022
Q1 		$526K Sell
23,360
-4,400
-16% -$93.6K ﹤0.01% 1168
2021
Q4 		$550K Hold
27,760
– – ﹤0.01% 1279
2021
Q3 		$546K Hold
27,760
– – ﹤0.01% 1299
2021
Q2 		$611K Buy
27,760
+10,400
+60% +$231K ﹤0.01% 1232
2021
Q1 		$413K Hold
17,360
– – ﹤0.01% 1296
2020
Q4 		$454K Hold
17,360
– – ﹤0.01% 1209
2020
Q3 		$302K Hold
17,360
– – ﹤0.01% 1234
2020
Q2 		$292K Buy
+17,360
New +$244K ﹤0.01% 1230

Other funds holding CORT

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
LTAS
Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
BC
Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
EF
Evanson Financial Mclean, Virginia $2.04B AUM
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Handelsbanken Fonder's CORT Position: Q2 2026 in Review

Handelsbanken Fonder increased its Corcept Therapeutics (CORT) stake by 28% in Q2 2026, buying an estimated $489K and bringing the position to 36,881 shares worth $3.21M. The position accounts for 0.01% of the portfolio, ranked #639.

Handelsbanken Fonder first reported a position in CORT in Q2 2020 and has held it in 25 quarters since. 44 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Handelsbanken Fonder held 36,881 shares of Corcept Therapeutics worth $3.21M as of Q2 2026.
  • Handelsbanken Fonder bought 8,100 Corcept Therapeutics shares in Q2 2026, an estimated $489K.
  • Corcept Therapeutics made up 0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #639 holding.
  • Handelsbanken Fonder first reported a position in Corcept Therapeutics in Q2 2020 and has held it in 25 quarters since.
  • 44 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.